Taha Al-Juhaishi to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Taha Al-Juhaishi has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.704
-
CAR-T in B-Cell Lymphomas: The Past, Present, and Future. Clin Lymphoma Myeloma Leuk. 2022 04; 22(4):e261-e268.
Score: 0.671
-
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age. Leukemia. 2026 May; 40(5):1009-1017.
Score: 0.229
-
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2025 Aug; 31(8):494-504.
Score: 0.216
-
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. Am J Hematol. 2025 Jun; 100(6):987-997.
Score: 0.212
-
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma. 2022 03; 63(3):710-721.
Score: 0.168
-
Perspectives on chemotherapy for the management of double-hit lymphoma. Expert Opin Pharmacother. 2020 Apr; 21(6):653-661.
Score: 0.150
-
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv. 2026 Mar 24; 10(6):1979-1991.
Score: 0.057